Abstract
Lymphangioleiomyomatosis (LAM) is a rare systemic disease characterized by proliferation of atypical smooth muscle-like cells and cystic destruction of the lung parenchyma. <b>Aim:</b> To evaluate parameters of pulmonary function tests (PFTs) and their prognostic value in patients with sporadic LAM. <b>Materials and methods:</b> This retrospective study included baseline data from 101 female patients with sporadic LAM who lived in different regions of Russia. All of them underwent functional testing and treatment in Moscow clinics (Pulmonology Research Institute, Sechenov University, City Clinical Hospital named after D.D.Pletnev) in 2009-2020. The disease was diagnosed based on the LAM diagnostic criteria formulated by a group of experts at the initiative of the ERS. <b>Results:</b> The obstructive ventilatory defect was detected in 75 (74 %) patients, restrictive ventilatory defect - in 4 (4 %) patients. There were no pulmonary ventilation disorders in 22 (22 %) patients. The mean FEV<sub>1</sub> value was 62±29 %pred., FEV<sub>1</sub>/VC - 56±21 %, RV - 172±73 %pred., RV/TLC- 141±42 %pred., ITGV - 139±43 %pred. A decrease in DL<sub>CO</sub> was found in 89 (92 %) out of 97 examined patients. The mean DL<sub>CO</sub> value was 48±23 %pred., K<sub>CO</sub> - 54±22 %pred. During the observation period, lung transplantation (LT) was performed in 7 women (4 - bilateral LT, 2 - unilateral LT, and 1 - bilateral LT twice). Of the 94 patients who did not undergo LT, 15 women died. The median transplant-free survival was 8.6 years. The Cox regression model showed that baseline DL<sub>CO</sub> and FEV<sub>1</sub> were the main prognostic physiologic factors. <b>Conclusion:</b> The impairment of DL<sub>CO</sub> and the obstructive ventilatory defect predominates in sporadic LAM. DL<sub>CO</sub> and FEV<sub>1</sub> are the most important predictors of survival.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.